We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $1.67B
1-Year Est. Return 7.53%
This Fund
S&P 500
This Quarter Est. Return
-12.59%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
–
AUM
$6.47B
AUM Growth
-$1.17B
Cap. Flow
+$229M
Cap. Flow %
3.54%
Top 10 Hldgs %
71.2%
Holding
88
New
3
Increased
8
Reduced
7
Closed
12

Top Buys

Rank Stock Value
1
SE icon
Sea Limited
SE
+$271M
2
CRM icon
Salesforce
CRM
+$190M
3
LI icon
Li Auto
LI
+$121M
4
YSG
Yatsen Holding
YSG
+$113M
5
ENFN
Enfusion, Inc.
ENFN
+$101M

Top Sells

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$205M
2
BEAM icon
Beam Therapeutics
BEAM
+$126M
3
BABA icon
Alibaba
BABA
+$106M
4
ILMN icon
Illumina
ILMN
+$68M
5
BILI icon
Bilibili
BILI
+$42.2M

Sector Composition

Rank Sector Weight
1 Healthcare 48.41%
2 Consumer Discretionary 29.78%
3 Technology 11.51%
4 Communication Services 4.08%
5 Consumer Staples 3.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMCR icon
51
Immunocore
IMCR
$1.7B
$9.51M 0.15%
277,754
– –
RLYB icon
52
Rallybio
RLYB
$84.7M
$8.62M 0.13%
112,959
– –
PYXS icon
53
Pyxis Oncology
PYXS
$185M
$8.39M 0.13%
+764,406
New +$8.75M
ROOT icon
54
Root
ROOT
$895M
$8.06M 0.12%
144,444
– –
RXDX
55
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$7.91M 0.12%
200,000
– –
HIPO icon
56
Hippo Holdings
HIPO
$777M
$7.84M 0.12%
110,868
– –
SRZN icon
57
Surrozen
SRZN
$223M
$7.73M 0.12%
80,000
– –
PRLD icon
58
Prelude Therapeutics
PRLD
$375M
$7.26M 0.11%
583,333
– –
ZTO icon
59
ZTO Express
ZTO
$18.2B
$7.24M 0.11%
256,453
– –
PATH icon
60
UiPath
PATH
$6.52B
$6.47M 0.1%
150,000
– –
DSGN icon
61
Design Therapeutics
DSGN
$751M
$6.02M 0.09%
280,991
– –
EM
62
DELISTED
Smart Share Global Ltd
EM
$5.96M 0.09%
4,080,000
– –
TCRX icon
63
TScan Therapeutics
TCRX
$48.5M
$5.77M 0.09%
1,282,976
– –
MREO
64
Mereo BioPharma
MREO
$48.9M
$4.76M 0.07%
2,976,121
– –
BEDU
65
DELISTED
Bright Scholar Education Holdings
BEDU
$4.62M 0.07%
996,449
– –
MOGU
66
MOGU Inc
MOGU
$16.4M
$3.97M 0.06%
870,581
– –
UXIN
67
Uxin Ltd
UXIN
$306M
$3.63M 0.06%
22,973
– –
DNUT icon
68
Krispy Kreme
DNUT
$562M
$3.57M 0.06%
188,638
– –
MNSO icon
69
MINISO
MNSO
$3.88B
$2.61M 0.04%
252,322
– –
COIN icon
70
Coinbase
COIN
$42.2B
$2.52M 0.04%
10,000
-60,000
-86% -$17.4M
CCC
71
CCC Intelligent Solutions
CCC
$3.55B
$2.28M 0.04%
200,000
– –
RDGT
72
Ridgetech Inc
RDGT
$692K
$1.82M 0.03%
134
– –
SFUN
73
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$1.25M 0.02%
327,720
– –
LEAP.U
74
DELISTED
Ribbit LEAP, Ltd. Units, each consisting of one Class A Ordinary Share, and one fifth of one Warrant
LEAP.U
$497K 0.01%
50,000
– –
SRZNW icon
75
Surrozen Inc Warrant
SRZNW
$36.6K
$460K 0.01%
399,999
– –
1 2
3
4

Similar funds

TFS
Thoroughbred Financial Services Brentwood, Tennessee $1.67B AUM 37.77% 1-Year Est. Return
GC
Garde Capital Seattle, Washington $1.67B AUM 13.9% 1-Year Est. Return
PA
Proem Advisors Dallas, Texas $1.68B AUM 199.97% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
NRI
NFP Retirement Inc Aliso Viejo, California $1.67B AUM 13.03% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return

HHLR Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, HHLR Advisors held 88 positions worth $6.47B, down 15% from $7.65B the previous quarter. Its ten largest holdings account for 71% of the portfolio.

HHLR Advisors deployed $229M of net new capital in Q4 2021, opening 3 new positions and adding to 8 existing holdings. Its largest new stake was Enfusion, Inc.: 4,975,183 shares worth $104M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 58% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Pinduoduo, an estimated $205M trimmed.

  • HHLR Advisors's largest Q4 2021 buy was Enfusion, Inc.: 4,975,183 shares worth $104M.
  • HHLR Advisors added most to Sea Limited in Q4 2021, an estimated $271M increase.
  • HHLR Advisors's biggest Q4 2021 reduction was Pinduoduo, cutting an estimated $205M.
  • HHLR Advisors fully exited Beam Therapeutics in Q4 2021, selling an estimated $126M.
  • HHLR Advisors's ten largest holdings make up 71% of its $6.47B portfolio in Q4 2021.
  • HHLR Advisors opened 3 new positions and closed 12 in Q4 2021.
  • HHLR Advisors's portfolio value fell 15% quarter-over-quarter to $6.47B.

Based on HHLR Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.